AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has submitted a certificate dated August 8, 2025 from its Registrar and Transfer Agent, Integrated Registry Management Services Private Limited, to the stock exchanges. The certificate confirms compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This regulation pertains to the timely processing and confirmation of dematerialisation (demat) of physical share certificates. The filing was signed by Manasa R, Company Secretary, on August 12, 2025. This is a routine regulatory compliance submission made periodically by listed companies.
No material impact on shareholders or stock price. This is a standard procedural compliance filing with no business or financial implications.